Sign inJoin waitlistJoin the waitlist

DR

Douglas Richman

Professor Emeritus · University of California (San Diego) Medical Center

Credentials: · ·

History

University of California (San Diego) Medical Center
Present

Infectious Disease
Internal Medicine

Research

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Science · 1997 · 2,691 citations
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial
New England Journal of Medicine · 1987 · 2,322 citations
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Science · 1997 · Last of 7 authors · 1,908 citations

Susan Little
99 papers
Diane Havlir
47 papers
Joseph Wong
43 papers
Daniel Kuritzkes
38 papers
VJ
Victoria Johnson
34 papers
MH
Martin Hirsch
29 papers
JM
John Mellors
28 papers
Margaret Fischl
28 papers
Stephen Spector
27 papers
JM
John Allen Mccutchan
25 papers
JG
John Guatelli
25 papers
Richard D’Aquila
24 papers

Grants

HIV and Other Pathogens with Epidemic Potential (HOPE) T32 Training Program
National Institute of Allergy and Infectious Diseases · T32
Contact PI · $8.3M · University of California, San Diego
1990–2021
San Diego Center for AIDS Research (SD CFAR)
National Institute of Allergy and Infectious Diseases · P30
Contact PI · $39.6M · University of California, San Diego
1994–2018
Martin Delaney Collaboratory to Eradicate HIV-1 Infection
National Institute of Allergy and Infectious Diseases · U19
Project lead · $2.1M · Univ of North Carolina Chapel Hill
2011–2017
Determinants of HIV Transmission
National Institute of Allergy and Infectious Diseases · P01
Project lead · $5.4M · University of California, San Diego
2008–2015

Clinical trials

Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2006–2010
Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2005